Skip to main content
. 2022 Apr 11;12(7):3372–3406. doi: 10.7150/thno.69999

Table 3.

Currently active clinical trials with MNs for treating skin diseases.

Type of skin disease Type of MNs Loading drugs Status Phase NCT identifier
Psoriasis DMN Calcipotriol-betamethasone dipropionate ointment Unknown Not applicable NCT02955576
AGA Solid MN 5% Minoxidil Unknown Phase 1 NCT02154503
Scars Fractional radiofrequency microneedling device - Completed Not applicable NCT03380845
Scars Solid MN - Unknown Not applicable NCT02025088
Scars Microneedling radiofrequency device - Completed Not applicable NCT02207738
Acne vulgaris Single radiofrequency microneedling device - Completed Not applicable NCT04213638
Facial pigmentation DMN - Enrolling by invitation Not applicable NCT04583852
Facial pigmentation Derma pen microneedling device Trichloroacetic acid Unknown Not applicable NCT03472235
Hyperhidrosis Fractional MN radiofrequency Botulinum toxin type A Completed Not Applicable NCT03054480
Hyperhidrosis Solid MN Botulinum toxin type A Completed Phase 1 NCT03203174
Hyperhidrosis Fractional MN radiofrequency - Completed Not Applicable NCT02823340
Birch pollen allergy Solid MN - Completed Phase 1 NCT01628484
Actinic keratosis Stainless steel MN Aminolevulinic acid Completed Not applicable NCT02594644
Actinic keratosis Solid MN Aminolevulinic acid Completed Not applicable NCT01812837
Actinic keratosis Solid MN Aminolevulinic acid Completed Phase 2 NCT02632110

Data obtained from http://www.clinicaltrials.gov.